search
Back to results

Efficacy of Exercise and Counseling Intervention on Relapse in Smoker With Depressive Disorders (STOB-ACTIV)

Primary Purpose

Smoking Cessation, Depression

Status
Terminated
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Exercise and counseling (for smoking cessation and physical activity)
Sponsored by
University Hospital, Montpellier
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Smoking Cessation focused on measuring Exercise,, counseling,, smoking cessation,, depressive disorders

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Ages 18 to 65 years
  • Must be able to give informed consent
  • Must live in the area for the next 3 months
  • Depression subscale of the Hospital Anxiety and Depression Scale, HADS-D score ≥ 8
  • Fagerstrom score > 3
  • Must be sedentary, have not participated regularly in aerobic physical exercise (for at least 20 minutes per day, 3 days per week) for the past six months.
  • Must be able to exercise at 60% maximum heart rate (MHR) (cleared by a physician)

Exclusion Criteria:

  • Cannot read or write fluently in the French language
  • Pregnancy or plans to attempt pregnancy
  • 60 minutes or more per week of moderate or vigorous physical activity
  • Currently in a quit smoking program
  • Currently using NRT of any kind or using any other quit smoking method or treatment
  • Poor willingness or inability to comply with protocol requirements

Medical problems:

  • Cancer treatment within the past 6 monthsPsychiatric Problems
  • Currently suicidal or psychotic, (or suicidal/psychotic in last 6 months)
  • Taking these specific medications for psychiatric problems: Mood stabilizer (Lithium, Depakote, Neurontin), Antipsychotics (Haldol, Clozaril, Risperdal)
  • Currently diagnosis of a bipolar disorder as assessed by MINI 5.0
  • Currently diagnosis of a alcohol dependence as assessed by MINI 5.0

Sites / Locations

  • University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Control

physical activity program

Arm Description

All subjects (intervention and control groups) participate in a smoking cessation program composed of a pharmacological treatment (including nicotine replacement therapy or varenicline) and counseling.

Experimental group subjects were required to attend 2 supervised exercise sessions and 2 counseling sessions during Week 1 and Week 2. Supervised exercise and counseling sessions are realized successively. For Week 3 to 8, participants were required to attend 1 supervised exercise session and 1 counseling session plus 1 home exercise session.

Outcomes

Primary Outcome Measures

Evaluation of smoking cessation verified by expired air carbon monoxide
To evaluate whether adding an established exercise and counseling intervention for depressed smokers to a standard smoking cessation treatment program improves smoking outcomes to 12 weeks after baseline ( 7-day point prevalence smoking abstinence verified by expired air carbon monoxide).

Secondary Outcome Measures

prevalence smoking abstinence
7-day point prevalence smoking abstinence verified by expired air carbon monoxide
Evaluation of Anxiety and Depression
The Anxiety and Depression are evaluated by the specific Scale (HADS)
Physical Fitness/Activity
Physical Fitness/Activity are evaluated by the 6 minutes Walk Test or TDM6 (Time Frame: Baseline; 8weeks after baseline), by Accelerometry (Time Frame: Baseline; -1, 9 weeks), by the evaluation of Physical self esteem (Time Frame: Baseline; 8, 12 weeks after baseline)with a self-questionnaire (IPAQ7)
Evaluation of Weight
Evaluation of quality of life
The quality of life is evaluated by a self-questionnaire (SF-12)
Cigarette Craving
The Cigarette Craving is evaluated by self-questionnaires: QSU and Fagerström test
Smoking Abstinence self Efficacy
The Smoking Abstinence self Efficacy is evaluated by the self-questionnaire (CSQ 12)

Full Information

First Posted
July 21, 2011
Last Updated
May 31, 2016
Sponsor
University Hospital, Montpellier
search

1. Study Identification

Unique Protocol Identification Number
NCT01401569
Brief Title
Efficacy of Exercise and Counseling Intervention on Relapse in Smoker With Depressive Disorders
Acronym
STOB-ACTIV
Official Title
STOB-ACTIV: The Efficacy of Exercise and Counseling for Depressed Patients as an Aid for Smoking Cessation, a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
May 2016
Overall Recruitment Status
Terminated
Why Stopped
Difficulties for recruiting patients
Study Start Date
October 2010 (undefined)
Primary Completion Date
March 2013 (Actual)
Study Completion Date
March 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Montpellier

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study investigated the efficacy of an exercise and counseling intervention for depressed smokers (depression subscale of the Hospital Anxiety and Depression Scale, HADS-D score ≥ 8) in term of likelihood of smoking abstinence. Participants were randomized to 8 weeks of intervention: individually delivered exercise and counseling (for smoking cessation and physical activity) or control: health education contact control condition.
Detailed Description
This study investigated the efficacy of an exercise and counseling intervention for depressed smokers (depression subscale of the Hospital Anxiety and Depression Scale, HADS-D score ≥ 8) in term of likelihood of smoking abstinence. Participants were randomized to 8 weeks of group delivered exercise and counseling (for smoking cessation and physical activity) or a health education contact control condition. The investigators assess this intervention in a randomized controlled trial of 96 depressed adults smokers recruited by advertisements in local print allocated into one of the two groups (intervention group vs. control group) during a 8-week period and 3 follow-up visits (12, 24, 52 weeks after baseline). All subjects (intervention and control groups) participate in a smoking cessation program composed of a pharmacological treatment (including nicotine replacement therapy or varenicline) and counseling.Experimental group subjects were required to attend 2 supervised exercise sessions and 2 counseling sessions during Week 1 and Week 2. Supervised exercise and counseling sessions are realized successively. For Week 3 to 8, participants were required to attend 1 supervised exercise session and 1 counseling session plus 1 home exercise session.Supervized exercise session consist of 5-min warm-up, 30 min of aerobic activity (stationary bikes), and a 5-min cooldown with stretching. The training intensity is of 60 to 80% maximum heart rate. The sessions are supervised by an exercise specialist who verified and documented the heart rates. Home exercise session consist of 45 min of aerobic exercise (walking, cycling, or running). The training intensity is 6 to 7 on breathlessness visual analog scale.The smoking counseling sessions included the following components: review of a participant's smoking history and motivation to quit, help in the identification of high-risk situations, management of cigarette craving and the generation of problem-solving strategies to deal with such situations.Exercise counseling sessions designed to motivate increased regular physical activity and short bouts of exercise in response to negative affect and urges to smoke. The goal of this intervention was to increase activity level.Health education group subjects were required to participate 75-minute supervised sessions with the same frequency of experimental group. Participants in the health education condition received information on a variety of health topics including sleep hygiene, nutrition, stress and health screening tests for cancer prevention. Participants were also asked to read handouts on health education topics covered during the session.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Smoking Cessation, Depression
Keywords
Exercise,, counseling,, smoking cessation,, depressive disorders

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
70 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
Active Comparator
Arm Description
All subjects (intervention and control groups) participate in a smoking cessation program composed of a pharmacological treatment (including nicotine replacement therapy or varenicline) and counseling.
Arm Title
physical activity program
Arm Type
Experimental
Arm Description
Experimental group subjects were required to attend 2 supervised exercise sessions and 2 counseling sessions during Week 1 and Week 2. Supervised exercise and counseling sessions are realized successively. For Week 3 to 8, participants were required to attend 1 supervised exercise session and 1 counseling session plus 1 home exercise session.
Intervention Type
Behavioral
Intervention Name(s)
Exercise and counseling (for smoking cessation and physical activity)
Intervention Description
Exercise and counseling (for smoking cessation and physical activity)
Primary Outcome Measure Information:
Title
Evaluation of smoking cessation verified by expired air carbon monoxide
Description
To evaluate whether adding an established exercise and counseling intervention for depressed smokers to a standard smoking cessation treatment program improves smoking outcomes to 12 weeks after baseline ( 7-day point prevalence smoking abstinence verified by expired air carbon monoxide).
Time Frame
12 weeks after baseline
Secondary Outcome Measure Information:
Title
prevalence smoking abstinence
Description
7-day point prevalence smoking abstinence verified by expired air carbon monoxide
Time Frame
(Baseline, 8, 12, 24, 52 weeks after baseline)
Title
Evaluation of Anxiety and Depression
Description
The Anxiety and Depression are evaluated by the specific Scale (HADS)
Time Frame
Baseline; 8, 12, 24, 52 weeks after baseline
Title
Physical Fitness/Activity
Description
Physical Fitness/Activity are evaluated by the 6 minutes Walk Test or TDM6 (Time Frame: Baseline; 8weeks after baseline), by Accelerometry (Time Frame: Baseline; -1, 9 weeks), by the evaluation of Physical self esteem (Time Frame: Baseline; 8, 12 weeks after baseline)with a self-questionnaire (IPAQ7)
Time Frame
Baseline, 8 weeks 12, 24, 52 weeks after baseline
Title
Evaluation of Weight
Time Frame
Baseline; 8,12, 24, 52 weeks after baseline
Title
Evaluation of quality of life
Description
The quality of life is evaluated by a self-questionnaire (SF-12)
Time Frame
Baseline; 8, 12 weeks after baseline
Title
Cigarette Craving
Description
The Cigarette Craving is evaluated by self-questionnaires: QSU and Fagerström test
Time Frame
Baseline; 8, 12 weeks after baseline
Title
Smoking Abstinence self Efficacy
Description
The Smoking Abstinence self Efficacy is evaluated by the self-questionnaire (CSQ 12)
Time Frame
Baseline; 8, 12 weeks after baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Ages 18 to 65 years Must be able to give informed consent Must live in the area for the next 3 months Depression subscale of the Hospital Anxiety and Depression Scale, HADS-D score ≥ 8 Fagerstrom score > 3 Must be sedentary, have not participated regularly in aerobic physical exercise (for at least 20 minutes per day, 3 days per week) for the past six months. Must be able to exercise at 60% maximum heart rate (MHR) (cleared by a physician) Exclusion Criteria: Cannot read or write fluently in the French language Pregnancy or plans to attempt pregnancy 60 minutes or more per week of moderate or vigorous physical activity Currently in a quit smoking program Currently using NRT of any kind or using any other quit smoking method or treatment Poor willingness or inability to comply with protocol requirements Medical problems: Cancer treatment within the past 6 monthsPsychiatric Problems Currently suicidal or psychotic, (or suicidal/psychotic in last 6 months) Taking these specific medications for psychiatric problems: Mood stabilizer (Lithium, Depakote, Neurontin), Antipsychotics (Haldol, Clozaril, Risperdal) Currently diagnosis of a bipolar disorder as assessed by MINI 5.0 Currently diagnosis of a alcohol dependence as assessed by MINI 5.0
Facility Information:
Facility Name
University Hospital
City
Montpellier
ZIP/Postal Code
34090
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
34611902
Citation
Hartmann-Boyce J, Theodoulou A, Farley A, Hajek P, Lycett D, Jones LL, Kudlek L, Heath L, Hajizadeh A, Schenkels M, Aveyard P. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev. 2021 Oct 6;10(10):CD006219. doi: 10.1002/14651858.CD006219.pub4.
Results Reference
derived
PubMed Identifier
26683252
Citation
Bernard P, Ninot G, Cyprien F, Courtet P, Guillaume S, Georgescu V, Picot MC, Taylor A, Quantin X. Exercise and Counseling for Smoking Cessation in Smokers With Depressive Symptoms: A Randomized Controlled Pilot Trial. J Dual Diagn. 2015;11(3-4):205-16. doi: 10.1080/15504263.2015.1113842.
Results Reference
derived

Learn more about this trial

Efficacy of Exercise and Counseling Intervention on Relapse in Smoker With Depressive Disorders

We'll reach out to this number within 24 hrs